Join leading experts as they explore the latest advances in sustained delivery that are transforming the care of patients with retinal vascular disease. This dynamic recorded symposium will examine the role of long-acting therapies (from the port delivery system [PDS] with ranibizumab to emerging tyrosine kinase inhibitors [TKIs] and investigational gene therapies) that are designed to reduce treatment burden and optimize outcomes. Don t miss this essential and practical discussion of novel and emerging strategies that are redefining what is possible in retinal care.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 523 Route 303
Pricing
97% of listed courses are free
34 of 35 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Communication & Shared Decision-Making
- Dermatology
- Gastroenterology
- General Pediatrics
- Hematology
- Medical Oncology
- Nephrology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Psychotic Disorders
- Rheumatology
- Surgical Oncology
- Cross-Specialty
- GI & Liver
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Pediatrics
- Psychiatry
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedAug 21, 2026
-
Last day to claim creditAug 22, 2027 11 months left
-
Multiple Myeloma Research Foundation (MMRF) +1 Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma
-
Learner’s Digest International (TM) Updates on Radioactive Iodine Delivery and Use
-
Association of Diabetes Care & Education Specialists Automated Insulin Delivery 101: Core Concepts & Patient Selection
-
Paradigm Medical Communications, LLC Delivering on the Promise of Sustained Treatment: Innovations in Long-Term Disease Control
-
Paradigm Medical Communications, LLC The Many Faces of Neovascular Retinal Disease: Individualizing the Use of Sustained Delivery Therapy
-
Paradigm Medical Communications, LLC Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies
